Ying-Qin Li

1.4k citations
17 papers · 786 indexed · h-index 16
    • Cancer-related molecular mechanisms research 5
    • MicroRNA in disease regulation 5
    • RNA modifications and cancer 5
    • Cancer-related gene regulation 5
    • Epigenetics and DNA Methylation 4
    • RNA Research and Splicing 3
    • Circular RNAs in diseases 2
    • Wnt/β-catenin signaling in development and cancer 2

Ying-Qin Li

17 papers receiving 780 citations

Peers

Ying-Qin Li
Comparison fields: 5 of 71
  • Cancer Research 415
  • Molecular Biology 550
  • Otorhinolaryngology 32
  • Oncology 194
  • Immunology 110
Replace Qing-Mei He with:
Qing-Mei He China
Federica Ganci Italy
George Koutsodontis Greece
Fátima Solange Pasini Brazil
Zsuzsa Rákosy Hungary
Irene Arroyo‐Solera Spain
Angela Queisser Germany
Bo Gong Japan
Takashi Ishigami Japan
Panqi Fang China
Ying-Qin Li relative to Qing-Mei He China Qing-Mei He's profile →
Citations per field
00.5×3.6×
Qing-Mei He · 1×
Citations per year

Countries citing papers authored by Ying-Qin Li

Since Specialization
Citations

This map shows the geographic impact of Ying-Qin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Qin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Qin Li more than expected).

Fields of papers citing papers by Ying-Qin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying-Qin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Qin Li. The network helps show where Ying-Qin Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ying-Qin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ying-Qin Li Line = papers co-authored together Ying-Qin Li links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 201824
2 201835
3 20188
4 2018106
5 2017174
6 201725
7 201752
8 201636
9 201530
10 201526
11 201521
12 201544
13 201526
14 201525
15 201430
16 201421
17 2013103

About Ying-Qin Li

Ying-Qin Li is a scholar working on Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 17 papers that have together received 786 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers), RNA Research and Splicing (3 papers), Circular RNAs in diseases (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cancer Research (415 citations), Molecular Biology (550 citations) and Otorhinolaryngology (32 citations). Ying-Qin Li has collaborated with scholars based in China and United States. Frequent co-authors include Na Liu, Jun Ma, Qing-Mei He, Ying Sun, Xiao-Jing Yang, Yaqin Wang, Yan‐Ping Mao, Xianyue Ren, Xin-Ran Tang and Ya-Fei Xu. Their work appears in journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026